{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:04:24Z","timestamp":1791331464171,"version":"4.3.1"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>Renal cancer (RC) presents a challenge with increasing incidence and mortality. This study compares RC cancer-specific survival (CSS) and overall survival (OS) based on histological type.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Study design<\/jats:title>\n<jats:p>This population-based retrospective cohort study covers 1995\u20132017, utilizing cases from the Finnish Cancer Registry. Comorbidity, procedure and treatment information from 1995\u20132018 were obtained from the national health care registry, while death data originated from the national death certificate registry.<\/jats:p>\n<jats:p>RC cases were categorized by histology to analyze CSS and OS via Fine and Gray\u2019s proportional sub-hazards model and Cox regression (adjusting for age, tumor extent, Charlson comorbidity index and treatment).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The final cohort included 14,413 patients, predominantly ccRCC (75.5%), followed by papillary RCC (pRCC),5.8% and chromophobe RCC (chRCC) 2.1%. Univariate analysis showed better OS for non-ccRCC patients, with 5-year survival (5ySR) of 72.6% (95% CI 70.3\u201374.7%), compared to ccRCC (62.7%, 95%CI 61.8\u201363.5). Among non-ccRCC, the 5ySRs were as follows: pRCC 74.3% (95%CI 71.2\u201377.2), chRCC 82.2% (95% CI 77.2\u201386.1), sarcomatoid variants (sarcRC) 29.2% (95% CI 20.6\u201338.3), and collecting duct carcinoma (CDC) 23.5% (95%CI 7.3\u201344.9). Non-ccRCC showed improved CSS compared to ccRCC (sHR 0.69, 95% CI 0.60\u20130.78). Favorable CSS for chRCC (sHR 0.28, 95% CI 0.18\u20130.43) and pRCC (sHR 0.66, 95% CI 0.56\u20130.78), while sarcRC (sHR 1.83, 95% CI 1.36\u20132.46) and CDC (sHR 3.19, 95% CI 2.01\u20135.08) showed poorer CSS. Overall, non-ccRCC had a better prognosis, driven by pRCC and chRCC, whereas sarcRC and CDC had poor prognoses. CSS has improved over time, with a 62% reduction in death risk since 1995.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Our results demonstrate that the histological subtype is a powerful predictor of survival. Histology should be used more in clinical decision-making. Having a histological confirmation would tailor the selection of treatment: surgical management for aggressive and ccRCC and conservative management for less aggressive histological types.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0329000","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T17:37:38Z","timestamp":1753983458000},"page":"e0329000","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Renal cancer survival in clear cell renal cancer compared to other types of tumor histology: A population-based cohort study"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4787-3252","authenticated-orcid":true,"given":"Teesi","family":"Sepp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Poyhonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4036-3856","authenticated-orcid":true,"given":"Anneli","family":"Uusk\u00fcla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Kotsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Veitonm\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teuvo L. J.","family":"Tammela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksei","family":"Baburin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teemu J.","family":"Murtola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"pone.0329000.ref001","unstructured":"European cancer information system. Europa.eu. Published October 19, 2017. [cited September 19, 2023]. Available from: https:\/\/ecis.jrc.ec.europa.eu\/explorer.php?$0-0$1-AE28E$4-1,2$3-All$6-0,85$5-2020,2020$7-7$2-All$CEstByCancer$X0_8-3$CEstRelativeCanc$X1_8-3$X1_9-AE27$CEstBySexByCancer$X2_8-3$X2_-1-1"},{"key":"pone.0329000.ref002","author":"J Ferlay","year":"2024"},{"issue":"5","key":"pone.0329000.ref003","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.euo.2021.05.005","article-title":"Mortality Trends from Urologic Cancers in Europe over the Period 1980-2017 and a Projection to 2025","volume":"4","author":"P Bertuccio","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"pone.0329000.ref004","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2014.10.002","article-title":"International variations and trends in renal cell carcinoma incidence and mortality","volume":"67","author":"A Znaor","year":"2015","journal-title":"Eur Urol"},{"issue":"1","key":"pone.0329000.ref005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of Renal Cell Carcinoma","volume":"75","author":"U Capitanio","year":"2019","journal-title":"Eur Urol"},{"key":"pone.0329000.ref006","unstructured":"Statistics and research. Sy\u00f6p\u00e4rekisteri. [cited 14 September 2024]. Available from: https:\/\/cancerregistry.fi\/."},{"issue":"4","key":"pone.0329000.ref007","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/21681805.2019.1624610","article-title":"Burden of renal cancer in Nordic countries","volume":"53","author":"SH N\u00e6raa","year":"2019","journal-title":"Scand J Urol"},{"issue":"6","key":"pone.0329000.ref008","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.juro.2011.02.059","article-title":"Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohort","volume":"185","author":"SP Kim","year":"2011","journal-title":"J Urol"},{"issue":"11","key":"pone.0329000.ref009","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/j.1464-410X.2008.08259.x","article-title":"A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study","volume":"103","author":"U Capitanio","year":"2009","journal-title":"BJU Int"},{"issue":"5","key":"pone.0329000.ref010","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.urolonc.2020.02.004","article-title":"Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis","volume":"38","author":"S Luzzago","year":"2020","journal-title":"Urol Oncol"},{"key":"pone.0329000.ref011","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5489\/cuaj.1760","article-title":"Contemporary incidence and mortality rates of kidney cancer in the United States","volume":"8","author":"G Gandaglia","year":"2014","journal-title":"Can Urol Assoc J"},{"key":"pone.0329000.ref012","doi-asserted-by":"crossref","first-page":"101883","DOI":"10.1016\/j.canep.2020.101883","article-title":"Stage-specific incidence trends of renal cancers in the East of England, 1999-2016","volume":"71","author":"A Herbert","year":"2021","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"pone.0329000.ref013","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.euo.2018.08.023","article-title":"Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States","volume":"2","author":"HD Patel","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"pone.0329000.ref014","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"JJ Hsieh","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"pone.0329000.ref015","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours","volume":"82","author":"H Moch","year":"2022","journal-title":"Eur Urol"},{"issue":"6","key":"pone.0329000.ref016","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ijc.34756","article-title":"Advances in non-clear cell renal cell carcinoma management: From heterogeneous biology to treatment options","volume":"154","author":"NR Wilson","year":"2024","journal-title":"Int J Cancer"},{"key":"pone.0329000.ref017","unstructured":"The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs. Part A: Renal Penile, and Testicular Tumours."},{"issue":"4","key":"pone.0329000.ref018","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/JU.0000000000001063","article-title":"Renal Cell Carcinoma: Comparison between Variant Histology and Clear Cell Carcinoma across All Stages and Treatment Modalities","volume":"204","author":"M Deuker","year":"2020","journal-title":"J Urol"},{"issue":"2","key":"pone.0329000.ref019","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.juro.2012.04.006","article-title":"Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage","volume":"188","author":"KA Keegan","year":"2012","journal-title":"J Urol"},{"issue":"4","key":"pone.0329000.ref020","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.juro.2009.12.035","article-title":"Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma","volume":"183","author":"BC Leibovich","year":"2010","journal-title":"J Urol"},{"issue":"4","key":"pone.0329000.ref021","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/0284186X.2017.1407039","article-title":"Nordic Cancer Registries - an overview of their procedures and data comparability","volume":"57","author":"E Pukkala","year":"2018","journal-title":"Acta Oncol"},{"key":"pone.0329000.ref022","unstructured":"Finnish Institute for Health and Welfare. Finnish National Social and Healthcare Data Collecting and Reporting System. [cited October 5, 2023]. Available from: https:\/\/thl.fi\/en\/web\/thlfi-en"},{"issue":"6","key":"pone.0329000.ref023","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"H Quan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"2","key":"pone.0329000.ref024","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.eururo.2022.11.001","article-title":"European Association of Urology Guidelines Panel on Renal Cell Carcinoma Update on the New World Health Organization Classification of Kidney Tumours 2022: The Urologist\u2019s Point of View","volume":"83","author":"M Hora","year":"2023","journal-title":"Eur Urol"},{"issue":"2","key":"pone.0329000.ref025","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ije\/dyp392","article-title":"Measuring cancer survival in populations: relative survival vs cancer-specific survival","volume":"39","author":"D Sarfati","year":"2010","journal-title":"Int J Epidemiol"},{"issue":"49","key":"pone.0329000.ref026","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jncimonographs\/lgu024","article-title":"Cancer survival: an overview of measures, uses, and interpretation","volume":"2014","author":"AB Mariotto","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"3","key":"pone.0329000.ref027","article-title":"A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk","volume":"16","author":"RJ Gray","year":"1988","journal-title":"Ann Statist"},{"key":"pone.0329000.ref028","author":"PC Austin","year":"2017","journal-title":"Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Carolina Digital Repository (University of North Carolina at Chapel Hill)"},{"issue":"3","key":"pone.0329000.ref029","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.eururo.2020.06.053","article-title":"Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort","volume":"78","author":"A Finelli","year":"2020","journal-title":"Eur Urol"},{"issue":"1","key":"pone.0329000.ref030","article-title":"Trends in Renal-Cell Carcinoma Incidence and Mortality in the United States in the Last 2 Decades: A SEER-Based Study","volume":"17","author":"AM Saad","year":"2019","journal-title":"Clin Genitourin Cancer"},{"issue":"18","key":"pone.0329000.ref031","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/jnci\/djj362","article-title":"Rising incidence of small renal masses: a need to reassess treatment effect","volume":"98","author":"JM Hollingsworth","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"pone.0329000.ref032","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.juro.2016.04.081","article-title":"Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-Analysis","volume":"196","author":"PM Pierorazio","year":"2016","journal-title":"J Urol"},{"issue":"3","key":"pone.0329000.ref033","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.eururo.2015.02.001","article-title":"Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry","volume":"68","author":"PM Pierorazio","year":"2015","journal-title":"Eur Urol"},{"issue":"1","key":"pone.0329000.ref034","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1464-410X.2012.11254.x","article-title":"Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged \u226575 years with multiple comorbidities","volume":"111","author":"M Sun","year":"2013","journal-title":"BJU Int"},{"issue":"8","key":"pone.0329000.ref035","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s00345-021-03798-z","article-title":"Renal cancer: overdiagnosis and overtreatment","volume":"39","author":"G Rosiello","year":"2021","journal-title":"World J Urol"},{"issue":"4","key":"pone.0329000.ref036","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/iju.13909","article-title":"Evolving trends in the surgical management of renal masses over the past two decades: A contemporary picture from a large prospectively-maintained database","volume":"26","author":"K Chen","year":"2019","journal-title":"Int J Urol"},{"issue":"7","key":"pone.0329000.ref037","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jvir.2018.12.013","article-title":"Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes","volume":"30","author":"W Zhou","year":"2019","journal-title":"J Vasc Interv Radiol"},{"issue":"12","key":"pone.0329000.ref038","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1161\/CIRCULATIONAHA.117.030114","article-title":"Perioperative Myocardial Injury After Noncardiac Surgery: Incidence, Mortality, and Characterization","volume":"137","author":"C Puelacher","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"pone.0329000.ref039","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1681\/ASN.2017020136","article-title":"Incident CKD after Radical or Partial Nephrectomy","volume":"29","author":"JT Leppert","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"pone.0329000.ref040","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2019.09.156","article-title":"Acute kidney injury after partial nephrectomy: transient or permanent kidney damage?-Impact on long-term renal function","volume":"7","author":"G Rosiello","year":"2019","journal-title":"Ann Transl Med"},{"issue":"1","key":"pone.0329000.ref041","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.eururo.2013.03.034","article-title":"Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management","volume":"65","author":"M Sun","year":"2014","journal-title":"Eur Urol"},{"issue":"6","key":"pone.0329000.ref042","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.eururo.2015.04.004","article-title":"Renal Tumor Biopsy for Small Renal Masses: A Single-center 13-year Experience","volume":"68","author":"PO Richard","year":"2015","journal-title":"Eur Urol"},{"issue":"4","key":"pone.0329000.ref043","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.eururo.2015.07.072","article-title":"Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy","volume":"69","author":"L Marconi","year":"2016","journal-title":"Eur Urol"},{"issue":"2","key":"pone.0329000.ref044","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2214\/AJR.06.0220","article-title":"Renal mass core biopsy: accuracy and impact on clinical management","volume":"188","author":"KE Maturen","year":"2007","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"pone.0329000.ref045","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"pone.0329000.ref046","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/cam4.578","article-title":"Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors","volume":"5","author":"K Schwartz","year":"2016","journal-title":"Cancer Med"},{"issue":"2","key":"pone.0329000.ref047","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/cncr.27690","article-title":"Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics","volume":"119","author":"W-H Chow","year":"2013","journal-title":"Cancer"},{"issue":"1","key":"pone.0329000.ref048","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s12891-021-04379-2","article-title":"Testing the proportional hazards assumption in cox regression and dealing with possible non-proportionality in total joint arthroplasty research: methodological perspectives and review","volume":"22","author":"I Kuitunen","year":"2021","journal-title":"BMC Musculoskelet Disord"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0342010","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000}}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0329000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T17:37:51Z","timestamp":1753983471000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0329000"}},"subtitle":[],"editor":[{"given":"Yuki","family":"Arita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0329000","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]}}}